Results 161 to 170 of about 49,135 (301)

Dabigatran accumulation in acute kidney injury: is more better than less to prevent bleeding? A case report

International Journal of Emergency Medicine
Dabigatran is an oral anticoagulant that is mainly renally excreted. Despite its efficacy in preventing thromboembolic events, concerns arise regarding bleeding complications in patients with acute kidney injury. Idarucizumab is its specific antidote and
Rafik Matbouli, Olivier Pantet, Julien Castioni, Nima Vakilzadeh, Lorenzo Alberio, Olivier Hugli   +5 more
doaj   +1 more source

Contemporary management of atrial fibrillation: what can clinical registries tell us about stroke prevention and current therapeutic approaches? [PDF]

, 2014
Al-Khatib, SM, Banerjee, A, Blendea, D, Camm, AJ, Conroy, JM, Cosio, FG, De Bono, J, G Cosio, MD, Guasch, E, Halperin, JL, Hess, PL, Kirchhof, P, Lip, GY, Nattel, S, Ruskin, J, Savelieva, I   +15 more
core   +1 more source

Thrombolysis in an Ischemic Stroke Patient on Dabigatran Anticoagulation: A Case Report [PDF]

, 2012
Luiz Carlos Porcello Marrone, A. Marrone
openalex   +1 more source

Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation [PDF]

, 2013
Ziad Hijazi, Stefan H. Hohnloser, Jonas Oldgren, Ulrika Andersson, Stuart J. Connolly, John W. Eikelboom, Michael D. Ezekowitz, Paul Reilly, Agneta Siegbahn, Salim Yusuf, Lars Wallentin   +10 more
openalex   +1 more source

Dabigatran Treatment Increased Closure Device-Related Thrombosis by Platelet Activation in Patients Undergoing Percutaneous Left Atrial Appendage Closure [PDF]

, 2021
Xiaoye Li, Xiaochun Zhang, Qinchun Jin, Yanli Li, Junbo Ge, Daxin Zhou, Qianzhou Lv   +6 more
openalex   +1 more source

Dabigatran etexilate in the prevention of cardioembolic complications in patients with non-valvular atrial fibrillation

, 2014
IS Yavelov
openalex   +2 more sources

Pharmacokinetic interaction between single and multiple doses of darunavir, in combination with cobicistat or ritonavir, and single-dose dabigatran etexilate in healthy adults

AAPS Open
Objective Darunavir (DRV) is a P-glycoprotein (P-gp) inhibitor. Dabigatran etexilate, prodrug of the anticoagulant dabigatran, is a P-gp probe substrate. This study evaluated the effect of single and multiple doses of DRV, coadministered with cobicistat (
Sandy Van Hemelryck, Erika Van Landuyt, Jay Ariyawansa, Martyn Palmer, Martine J. C. Kothe, Caroline Pollefliet   +5 more
doaj   +1 more source

@NEJM @Boehringer RE-LY (#Pradaxa dabigatran): 3rd request of retraction #AllTrials

, 2014
Jorge H Ramírez
openalex   +1 more source

Prevention of cerebral thromboembolism by oral anticoagulation with dabigatran after pulmonary vein isolation for atrial fibrillation: the ODIn-AF trial [PDF]

, 2023
Jan W. Schrickel, Thomas Beiert, Markus Linhart, Julian A. Luetkens, Jennifer Schmitz, Matthias Schmid, Gerhard Hindricks, Thomas Arentz, Christoph Stellbrink, Thomas Deneke, Harilaos Bogossian, Armin Sause, Daniel Steven, Bernd‐Dieter Gonska, Boris Rudic, Thorsten Lewalter, Markus Zabel, Tobias Geisler, Burghard Schumacher, Werner Jung, Thomas Kleemann, Armin Luik, Christian Veltmann, Martin Coenen, Georg Nickenig   +24 more
openalex   +1 more source

Clinical and economic consequences of using dabigatran or rivaroxaban in patients with non-valvular atrial fibrillation

, 2016
L. Silva Miguel, Jorge Ferreira
openalex   +1 more source